The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 336:1314-1316 May 1, 1997 Number 18
NextNext

Screening for Genetic Diseases

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
With better knowledge of the genetics of various diseases, testing for the underlying defects with the use of biochemical and molecular techniques is increasingly possible. The practical aim of these tests is the prevention and treatment of disease. The first widespread screening test was for the detection of phenylketonuria in newborns. In addition to screening newborns, there are other strategies for identifying genetic disorders. Screening for fetal disease has become common during pregnancy and includes searching for chromosomal defects (such as in Down's syndrome) with amniocentesis or chorionic-villus sampling. Screening of maternal blood for alpha-fetoprotein to detect neural-tube defects and . . . [Full Text of this Article]

References


Related Letters:

Genetic Screening of Adolescents
Spiegler G. E., Motulsky A. G.
Extract | Full Text  
N Engl J Med 1997; 337:639-640, Aug 28, 1997. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.